- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07566065
Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis (COMBAT)
Endovascular Treatment of Atherosclerotic Renal Artery Stenosis: A Prospective Randomized Controlled Study Comparing Covered Stents and Bare Metal Stents
Atherosclerotic renal artery stenosis is the most common cause of secondary hypertension , increasing the risk of cardiovascular and kidney-related complications. Some small-scale studies have suggested that covered stents are effective and safe, but high-quality evidence from large-scale studies in atherosclerotic renal artery stenosis remains limited.
This study aims to evaluate whether covered stents are more effective than bare metal stents in patients with atherosclerotic renal artery stenosis. Eligible participants will be randomly assigned to receive either a covered stent or a bare metal stent. Patients will be followed for 12 months to assess Changes in eGFR, 24-hour systolic blood pressure, and 24-hour diastolic blood pressure from baseline to 12 months were compared among the groups.
The results of this study may help improve treatment strategies and guide the selection of stent type for patients with this condition.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Xiongjing Jiang
- Telefonnummer: 86-010-88322387
- E-post: jiangxiongjing@163.com
Studera Kontakt Backup
- Namn: Hui Dong
- Telefonnummer: 86-010-88322385
- E-post: donghui666@sina.com
Studieorter
-
-
-
Beijing, Kina
- Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037
-
Kontakt:
- Hui Dong
- Telefonnummer: 15810161393
- E-post: donghui666@sina.com
-
Chongqing, Kina, 400016
- Department of Cardiovascular Medicine, Cardiovascular Research Center , The First Affiliated Hospital of Chongqing Medical University
-
Harbin, Kina
- The Second Affiliated Hospital of Harbin Medical University, Ha'erbin
-
Kontakt:
- Shuo Zhang
- Telefonnummer: 18645056661
- E-post: zhangshuoemail@163.com
-
Jilin, Kina, 130033
- China-Japan Union Hospital of Jilin University, Changchun, Lilin
-
Kontakt:
- Yuquan He
- Telefonnummer: 13944145413
- E-post: liuxueyan@jlu.edu.cn
-
-
Guangdong
-
Guangzhou, Guangdong, Kina, 510000
- The First Affiliated Hospital of Sun Yat-sen University
-
Kontakt:
- Wenhao Xia
- Telefonnummer: 020-87755766
- E-post: xiawhao@mail.sysu.edu.cn
-
-
Heilongjiang
-
Harbin, Heilongjiang, Kina, 150086
- The Second Affiliated Hospital of Harbin Medical University
-
Kontakt:
- Zhiyu Shi
- Telefonnummer: 18645056661
- E-post: zhangshuoemail@163.com
-
-
Henan
-
Zhengzhou, Henan, Kina, 450000
- Fuwai Central China Cardiovascular Hospital
-
Zhengzhou, Henan, Kina, 450007
- Zhengzhou Central Hospital Affiliated to Zhengzhou University
-
Kontakt:
- Shuhua Yu
- Telefonnummer: 0371-67690941
- E-post: 13613716677@139.com
-
-
Jiangsu
-
Nanjing, Jiangsu, Kina, 211800
- Nanjing Pukou People's Hospital(Liangjiang Hospital Southeast University)
-
-
Jiangxi
-
Nanchang, Jiangxi, Kina, 330038
- Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College)
-
-
Liaoning
-
Dalian, Liaoning, Kina, 116001
- Affilated Zhongshan Hospital of Dalian University
-
Dalian, Liaoning, Kina
- Frist Aiffiliated Hospital of Dalian Medical University
-
-
Shandong
-
Jinan, Shandong, Kina, 250012
- Qilu Hospital of Shandong University
-
Qingdao, Shandong, Kina
- Qingdao Hospital University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital)
-
-
Sichuan
-
Chengdu, Sichuan, Kina, 610031
- The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu
-
Kontakt:
- Zhen Zhang
- Telefonnummer: 13708042927
- E-post: 31350377@qq.com
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- 1) Renal artery diameter stenosis ≥60%; 2) Office systolic blood pressure ≥ 160 mmHg and/or office diastolic blood pressure ≥ 100 mmHg on at least two separate days without antihypertensive medication, or office systolic blood pressure ≥ 140 mmHg and/or office diastolic blood pressure ≥ 90 mmHg while on three antihypertensive drugs at conventional doses; 3) Serum creatinine < 264 μmol/L (3.0 mg/dL); 4) Affected kidney length ≥ 7.0 cm, with residual glomerular filtration rate (GFR) ≥ 10 mL/min;
Exclusion Criteria:
- 1) Unstable clinical condition rendering the patient intolerant to revascularisation therapy; 2) Urinary protein ≥2+; 3) Contrast medium allergy; 4) Renal artery anatomy unsuitable for revascularisation therapy; 5) Reference vessel diameter <3.5mm or >8mm. 6)Patients with non-atherosclerotic renal artery stenosis (such as fibromuscular dysplasia or Takayasu arteritis); 7)Reference vessel diameter < 3.5 mm or > 8 mm
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: bare metal stents group
|
Endovascular implantation of a bare metal stent in the renal artery.
|
|
Experimentell: covered stents group
|
Endovascular implantation of a covered stent in the renal artery
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in eGFR
Tidsram: 12 months
|
Change in estimated glomerular filtration rate (eGFR) at 12 months compared with baseline
|
12 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in 24-Hour Ambulatory Systolic Blood Pressure
Tidsram: 12 months
|
Change in 24-Hour Ambulatory Systolic Blood Pressure Compared With Baseline
|
12 months
|
|
Change in 24-Hour Ambulatory Diastolic Blood Pressure
Tidsram: 12 months
|
Change in 24-Hour Ambulatory Diastolic Blood Pressure Compared With Baseline
|
12 months
|
|
Change in Office Systolic Blood Pressure
Tidsram: 12 months
|
Change in Office Systolic Blood Pressure Compared With Baseline
|
12 months
|
|
Change in Office Diastolic Blood Pressure
Tidsram: 12 months
|
Change in Office Diastolic Blood Pressure Compared With Baseline
|
12 months
|
|
Change in Home Systolic Blood Pressure
Tidsram: 12 months
|
Change in Home Systolic Blood Pressure Compared With Baseline
|
12 months
|
|
Change in Home Diastolic Blood Pressure
Tidsram: 12 months
|
Change in Home Diastolic Blood Pressure Compared With Baseline
|
12 months
|
|
Change in antihypertensive medication burden
Tidsram: 12 months
|
Change in antihypertensive medication burden at 12 months compared with pre-procedure levels
|
12 months
|
|
Stent patency
Tidsram: 12 months
|
Stent patency at 12 months
|
12 months
|
|
Incidence of perioperative complications
Tidsram: 1 month
|
1 month
|
|
|
MACE
Tidsram: 12 months
|
Major adverse cardiovascular events (MACE) include cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and hospitalization for heart failure.
|
12 months
|
|
Renal Adverse Events
Tidsram: 12 months
|
Renal adverse events include a sustained decline in renal function (≥30% decrease in eGFR from baseline confirmed on repeat measurement), doubling of serum creatinine, initiation of renal replacement therapy (dialysis or kidney transplantation), or progression to end-stage renal disease.
|
12 months
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2026-0427
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .